102
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

The −675 4G/5G PAI-1 polymorphism confers genetic susceptibility to systemic lupus erythematosus, its clinical manifestations, and comorbidities in Mexican-Mestizo population

, , , , , , , , & show all
Pages 71-77 | Received 21 Aug 2019, Accepted 02 Dec 2019, Published online: 12 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Monika Katko, Erika Galgoczi, Annamaria Erdei, Annamaria Gazdag, Eszter Berta, Miklos Bodor, Ildiko Seres, Ildiko Hircsu, Arpad Badics, Bernadett Ujhelyi, Livia Sira, Harjit Pal Bhattoa & Endre V Nagy. (2021) The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease. Journal of Inflammation Research 14, pages 1883-1890.
Read now
Aly A Yousef, Faisal Y Mohamed, Naglaa F Boraey, Nagwa E Akeel, Attia A Soliman, Nevin M Waked, Mustafa I A Hashem, Hassan Shehata, Dalia S Fahmy, Ali Ismael, Lamya M Ibrahim, Mohamed A M Ibrahim, Hanan F Salem, Sherif M Yousry, Sherif F Osman, Rania A Fouad, Eman T Enan, Mohammed A Attia, Mona R Afify, Nancy M S Zeidan & Mohamed Nashat. (2020) Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study. Journal of Inflammation Research 13, pages 1103-1111.
Read now

Articles from other publishers (3)

Isela Montúfar-Robles, Rosa Elda Barbosa-Cobos, Juanita Romero-Díaz, Guillermo Valencia-Pacheco, Carlos Cabello-Gutiérrez & Julian Ramírez-Bello. (2023) The functional TNFAIP3 rs2230926T/G (Phe127Cys) variant confers risk to systemic lupus erythematosus in a Latin American population. Human Immunology, pages 110736.
Crossref
Rui Tang, Xiaohong Lyu, Hong Li & Jinlyu Sun. (2023) The 4G/5G polymorphism of plasminogen activator inhibitor type 1 is a predictor of allergic cough. Frontiers in Genetics 14.
Crossref
Carlo Selmi. (2020) Autoimmunity in 2019. Clinical Reviews in Allergy & Immunology 59:3, pages 275-286.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.